A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
about
Animal models for SARS and MERS coronavirusesA decade after SARS: strategies for controlling emerging coronavirusesA mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantChimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence.Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronavirusesProtease inhibitors targeting coronavirus and filovirus entrySingle-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelInhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity.Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission.Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages.Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.Development of animal models against emerging coronaviruses: From SARS to MERS coronavirusA review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses.The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokinesInhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survivalProtective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice.Animal models in virus research: their utility and limitations.The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.Antiviral lectins: Selective inhibitors of viral entry.Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice.Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapyChimpanzee adenoviral vectors as vaccines for outbreak pathogens.Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses.Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
P2860
Q26799857-C97771A8-000F-4C31-9BD8-E71FC3AC4D51Q28817689-B9634250-BFB0-4FB0-BBA4-9C1433DB3A2CQ30360627-864071E8-DD9F-4B5F-B1EC-5880CAED5880Q30404941-678FFE4D-B9C2-4323-847F-CF4F603AD331Q34120208-F6B618E4-249A-4CB2-9BED-1F0446FA0B20Q34190597-4222A633-5E71-44AD-A5B3-FB03920933AFQ34261516-E5A1BEC6-890D-46D3-9D5D-5F715851699CQ34461982-3DF5A984-03EB-449F-A405-52AD0D38EA0BQ34478750-94C99111-378E-413C-B2AF-25996AB710E3Q34894092-2A901A7C-022C-4FCE-95F5-883584A734C1Q35079166-77304D49-BA30-4AD6-85B3-F1B5C44AC3EBQ35111000-AFA8AB1A-FDE4-479F-801F-8F15EECF543CQ35612506-432252CC-3A96-4E30-B2B5-EA5384535F41Q35665893-402CE7D5-D11A-4159-AF69-7106A0EFFFA7Q35973652-7A102C3E-64C5-4442-8957-31733B2EA974Q36067731-D65FC8EC-6F6C-4916-84D8-A9DC677EDFF5Q36180681-CED3E515-5906-4926-94AA-7C242ECC9F00Q36691163-0C6006FB-680C-46E1-94EC-22121F958D1DQ36739375-77B19BB8-4D0D-4F96-9EB7-8C84E61F1340Q36931120-9866B6FF-B92D-47A3-8332-0BDF12575999Q37246874-C20E8733-AE35-480A-A235-F11C5F64BB7DQ37547432-04241D14-1957-415E-B221-193B19E0D76FQ37638963-F8965710-A4C8-4835-A997-65A2D4FC30EAQ38043556-7B01D333-2755-467A-9EE1-34FED3FBA469Q38718445-11491614-CF69-4657-A0A1-21D13782CEC6Q38891044-6663D61E-D6C1-4547-8218-60465705433CQ39279748-1A4740CC-9A63-4BAB-A269-A5A553264554Q39614017-5122D38A-44CB-4EA6-8809-83972A90A4E2Q39727842-D680F5FA-D457-4AA8-BFE0-4AB85CDDDAC0Q44106019-C47094C2-2AAB-4CC5-9DC8-B5E0F3D76983Q47253371-220C818B-2E74-4051-88F6-A8DAFA94CD6CQ57094095-D993B758-5792-42A9-8FCF-602B2119F02B
P2860
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@ast
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@en
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@nl
type
label
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@ast
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@en
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@nl
prefLabel
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@ast
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@en
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@nl
P2093
P2860
P50
P3181
P1433
P1476
A new mouse-adapted strain of ...... al agents in vitro and in vivo
@en
P2093
Craig W Day
Dale L Barnard
Matt Frieman
Sui Xiong Cai
Yohichi Kumaki
P2860
P304
P3181
P356
10.1016/J.VIROL.2009.09.023
P407
P577
2009-12-20T00:00:00Z